Вопросы гематологии/онкологии и иммунопатологии в педиатрии

Расширенный поиск

Bone Changes during and after Treatment of Childhood Acute Lymphoblastic Leukaemia


Introduction: Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, with a survival rate of 80%.  Major complications of leukemia include osteoporosis that requires both a clinically significant fracture history and low bone mineral density.

Objective: The present study aims to assess bone mineral density among acute lymphoblastic leukemia patients and survivors using dual-energy x-ray absorptiometry and serum insulin growth factor binding protein 3.

Methods: Thirty patients with ALL and thirty survivors who were diagnosed with ALL but completely recovered were enrolled in this study. Sex and age matched normal controls while full history was taken.  Patients and survivors were examined for anthropometric measurement. Laboratory including serum IGFBP3and dual-energy x-ray absorptiometry was done for all.

Results: It has been found out that patients and survivors showed a markedly lower bone mineral density than normal population but no history of fracture was found in survivors. In this study, the prevalence of low bone mineral density is 26/30 (86.6%) patients and 25/30 (83.3%) survivors. Also, there was a statistically significant decrease of DEXA scan measures in patients and survivors groups than the control group with a statistically significant decrease in both BMD and Z- score measures in patients and survivors groups than control group.

Conclusion: Patients and long-term survivors of childhood ALL are at risk for morbidity associated with low bone mineral density (BMD). They may benefit from interventions to optimize bone health as they age.

Об авторах

Seham Ragab


Belal Montaser


Nahed El-Ashmawy


Mahmoud El-Hawy



Для цитирования:

., ., ., . . Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2021;20(1).

For citation:

Ragab S., Montaser B., El-Ashmawy N., El-Hawy M. Bone Changes during and after Treatment of Childhood Acute Lymphoblastic Leukaemia. Pediatric Hematology/Oncology and Immunopathology. 2021;20(1). (In Russ.)

Просмотров: 10

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 1726-1708 (Print)
ISSN 2414-9314 (Online)